Abstract
The aim of this study was to investigate methods for the synthesis of highly pure, well-characterized analogues of the lipid core peptide (LCP) system. Difficulties synthesizing and purifying conventional LCP systems have led to the requirement for a technique to produce highly pure, LCP-based vaccines for potential use in human clinical trials. The current study describes methods for the attachment of lipophilic adjuvants onto multi-epitopic peptide vaccines. Described is the synthesis, using native chemical ligation, of a highly pure, tri-epitopic, group A streptococcal (GAS) lipopeptide vaccine candidate. Intranasal immunization of the described tri-epitopic GAS lipopeptide with the mucosal adjuvant cholera toxin B subunit induced high serum IgG antibody titers specific for each of the incorporated peptide epitopes.
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Adjuvants, Immunologic / pharmacology
-
Administration, Intranasal
-
Amino Acid Sequence
-
Animals
-
Chemistry, Organic / methods*
-
Cholera Toxin / pharmacology
-
Cysteine / chemistry
-
Drug Evaluation, Preclinical / methods
-
Epitopes*
-
Female
-
Immune Sera
-
Immunoglobulin G / analysis
-
Lipoproteins / chemical synthesis
-
Lipoproteins / immunology
-
Mice
-
Mice, Inbred Strains
-
Molecular Sequence Data
-
Streptococcal Vaccines / chemical synthesis*
-
Streptococcal Vaccines / immunology
-
Streptococcal Vaccines / pharmacology
-
Streptococcus pyogenes / immunology*
-
Vaccines, Synthetic / chemistry*
-
Vaccines, Synthetic / immunology
-
Vaccines, Synthetic / pharmacology
Substances
-
Adjuvants, Immunologic
-
Epitopes
-
Immune Sera
-
Immunoglobulin G
-
Lipoproteins
-
Streptococcal Vaccines
-
Vaccines, Synthetic
-
Cholera Toxin
-
Cysteine